◆ 会议时间：2021年10月8-9日
◆ 会议地点：虚拟会议
◆ 会议简介：
2021年第8届癌症免疫治疗大会-虚拟会议将于2021年10月8-9日举行，会议由WMA GmbH与ITOC协会、慕尼黑肿瘤中心(TZM)、癌症免疫治疗协会(SITC)、德国癌症协会(DKTK)以及慕尼黑综合癌症中心(CCCM)合作举办。该会议是欧洲领先的会议，为免疫肿瘤学领域的转化研究提供一个全球性的平台-宣译。ITOC系列会议是首屈一指的癌症免疫治疗教育、科学交流会议，旨在为所有从事免疫治疗的专业人士提供一个讨论早期临床药物研发，应对转化研究所面临的独特挑战的论坛；大会议题将侧重于最新的挑战和创新，特别强调联合治疗，免疫监测和生物标志物开发(未经本站许可，禁止复制摘录镜像本站任何内容-领域国际医学会议网)。
It aims at providing a forum for all professionals working in immunotherapy to discuss early clinical drug development and address the unique challenges of translational research.
The programme will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring and biomarker development(lingyuint).
At this conference, we are in particular addressing preclinical and clinical scientists, clinical investigators, postdoctoral fellows involved in cancer research, regulatory scientists, healthcare professionals and the pharmaceutical industry.
8th Immunotherapy of Cancer Conference (ITOC8)
Virtual Event, Worldwide
8 - 9 October 2021
Deadline for Abstract Submission
The deadline to submit abstracts is July 4, 2021 at 24:00 CEST.
点此提交摘要>>>Submit Abstract>>>
Notification of Acceptance
-
Note that the first/submitting author will receive all correspondence concerning the abstract and is responsible for informing the other authors of the status of the abstract and will automatically be listed as the presenting author.
-
Accepted abstracts will be presented as posters.
-
Some selected abstracts will be presented orally in plenary sessions.
-
Authors will be notified on acceptance and allocation by email by beginning of August 2021.
Presentations of abstracts
The submission of an abstract constitutes a formal commitment by the presenting author to present the abstract (if accepted) orally or as a poster in the session and the time assigned by the ITOC8 Programme Committee.
Publication of abstracts
Accepted abstracts will be published as a supplement to the "Journal for ImmunoTherapy of Cancer".
Poster Awards
All presenters of accepted poster presentations are automatically entered in the competition of the ITOC8 Poster Awards.
The winners will be announced in the final session of the ITOC8 virtual conference.
Topics for submission:
Abstracts can be submitted for the following topic categories:
-
Emerging concepts / New Agents
-
Tumor microenvironment and microbiome in Immunotherapy
-
Vaccine Therapy
-
Precision Medicine Meets Immunotherapy (Immuno-Monitoring)
-
"Lost in Translation"?
-
Cell Therapy in Solid Tumors
-
Cell Therapy in Haematologic Diseases
-
Combination Therapy
-
Young Researchers Session
Welcome
Dear Colleagues,
Dear Fellow Immuno-Oncologists,
I would like to invite you to join ITOC8 which will be the second virtual edition of the ITOC conference series.
With little prior warning we had to develop an online version of ITOC in 2020 due to the SARS-CoV2 pandemic.
Fortunately, this meeting was very well received by the participants and we will definitely keep some of the features in the future regardless of Corona.
This year cancer vaccines platforms have actually been instrumental to begin fighting the virus.
Nevertheless, it remains unclear whether and how fast the pandemic will be controlled. Therefore, we have organized ITOC8 again as a virtual meeting bringing together last years backbone and some further developments.
This allows us to offer you a cutting edge program covering cancer vaccines and checkpoint blockade to CD40 agonists and CAR T cells.
Numerous top speakers have already confirmed their attendance and we are all eager to spend two days of inspiring science together with people joining from all around the globe.
On behalf of the organizing committee, I cordially invite you to help us make this year’s ITOC conference again a successful and memorable event.
Sincerely,
Michael von Bergwelt MD, PhD
ITOC8 Conference President
注册费：
| Category |
from February to
September 8, 2021 |
from September 9, 2021 |
| Academia |
EUR 220,- |
EUR 240,- |
| Junior Participant(1) |
EUR 120,- |
EUR 140,- |
| Industry |
EUR 320,- |
EUR 340,- |
(1) The “Junior Participant” registration is available for Students under 30 years of age. Please provide a copy of a student ID at the moment of your registration either by fax to +43 1 405 13 83 918 or upload a jpeg, jpg, gif, bmp or png
(3) A Press ID confirming your status must be provided at the moment of your registration either by fax to +43 1 405 13 83 918 or upload a jpeg, jpg, gif, bmp or png
Payments should be made without charges to the beneficiary. Any bank charges will be claimed.
Clearly state the participant's name(s) and the invoice number on the bank transfer.
Please be informed, that due to the virtual meeting format, Creditcard payment is preferred.
As of October 1, 2021 ONLY creditcard payment will be possible. Thank you for your understanding.
What is covered by the registration fee?
-
Admission to all scientific sessions (Live, On-Demand, e-Poster)
-
Abstract book and programme (both online)
-
Admission to the virtual company corner
Cancellations:
Please note that only written cancellations addressed to ITOC c/o Vienna Medical Academy GmbH, Alser Straße 4, 1090 Vienna, Austria either per E-Mail: itoc@medacad.org or Fax: +43 1 405 13 83 918 can be accepted.
The following rules apply:
-
until June 1, 2021: full refund
-
from June 2, 2021 to August 1: 50% refund
-
as of August 2, 2021: no refund
Replacements
Any replacement (i.e. change of delegate name) of a confirmed registration is subject to a EUR 60,- charge per participant.
◆ 参会对象：
临床医生、药物开发人员，肿瘤学家、企业代表，以及从事癌症免疫治疗研究的相关专业人士等等。
|
